Retatrutide (10mg)
Retatrutide (10mg) is a multi-target triple agonist peptide engineered to hit GLP-1, GIP, and glucagon receptors. Designed to evaluate advanced weight loss and metabolic regulation, it delivers greater energy expenditure and appetite control in preclinical studies. High-purity lyophilized powder for laboratory research.
Tirzepatide (5mg)
Tirzepatide (5mg) is a dual GIP and GLP-1 receptor agonist designed to study advanced weight loss, lipid metabolism, and glycemic control. Engineered for high potency, this peptide targets dual incretin pathways to optimize metabolic research outcomes. Supplied as a high-purity lyophilized powder for laboratory use.